| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |